Indeed, the influence of variants within genes encoded for several enzymes involved in MDMA metabolism (especially CYP2D6 and COMT) and/or PD targets (especially the 5HT system) on the effects of MDMA in humans have been investigated. The gene discussed is CYP2D6; the disease is Parkinson disease.